1,839 results on '"Esophageal Fistula"'
Search Results
2. Primary Posterior Tracheopexy Prevents Tracheal Collapse (PORTRAIT)
- Author
-
For Wis(h)dom Foundation, Erasmus Medical Center, Great Ormond Street Hospital for Children NHS Foundation Trust, Karolinska University Hospital, and Maud Lindeboom, Principal investigator
- Published
- 2024
3. A case of refractory chylothorax due to an unenclosed esophageal hiatus after subtotal esophagectomy treated with lipiodol lymphangiography.
- Author
-
Kaneda, Koji, Miwa, Takeshi, Okumura, Tomoyuki, Numata, Yoshihisa, Fukasawa, Mina, Watanabe, Toru, Hashimoto, Isaya, Naruto, Norihito, and Fujii, Tsutomu
- Subjects
ESOPHAGEAL fistula ,THORACIC duct ,PATIENT positioning ,CHEST (Anatomy) ,CHYLOTHORAX ,LYMPHANGIOGRAPHY - Abstract
Background: Chylothorax, a rare but serious complication following esophagectomy, can lead to dehydration, malnutrition, and even mortality. Surgical intervention is considered when conservative treatment is ineffective; however, in some refractory cases, the cause of chylothorax remains unclear. We report a case of refractory chylothorax caused by abdominal chyle leakage into the pleural space via an unenclosed esophageal hiatus. Case presentation: A 66-year-old man was diagnosed with advanced esophageal squamous cell carcinoma. The patient underwent robot-assisted thoracoscopic subtotal esophagectomy in the prone position with retrosternal gastric tube reconstruction following neoadjuvant chemotherapy. The thoracic duct was ligated and resected because of tumor invasion. Chylothorax and chylous ascites were observed 2 weeks after surgery but did not improve despite conservative management with medications and drainage. Lymphoscintigraphy through the inguinal lymph node showed tracer accumulation in the fluid in both the abdominal and pleural spaces. Lipiodol lymphangiography revealed abdominal lymphoid leakage, but no leakage was detected from the thoracic duct or mediastinum. We considered that the chylothorax was caused by chylous ascites flowing into the pleural space via an unenclosed esophageal hiatus, and we performed surgical intervention. Laparotomy revealed abdominal chyle leakage and a fistula at the esophageal hiatus with the inflow of ascites into the thoracic cavity. Lipiodol lymphangiography was additionally performed for treating abdominal lymphorrhea after surgery, and resulted in the improvement of the chylothorax and ascites. The patient was discharged with no recurrence of chylothorax or chylous ascites. Conclusions: Refractory chylothorax can occur due to chylous ascites flowing into the pleural space via an unenclosed esophageal hiatus. When the site of chylothorax leakage is unclear, the possibility of inflowing chylous ascites via the unenclosed esophageal hiatus should be explored. Esophageal hiatus closure and lipiodol lymphangiography could be effective in treating refractory chylothorax of unknown cause after esophagectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Aortoesophageal fistula with hemorrhagic shock successfully treated with resuscitative endovascular balloon occlusion of the aorta.
- Author
-
Hirai, Tadayuki, Okajima, Masaki, Noda, Toru, and Goto, Yoshikazu
- Subjects
- *
ESOPHAGEAL surgery , *FISTULA , *HEMATEMESIS , *AORTIC diseases , *BLOOD vessels , *COMPUTED tomography , *THORACIC surgery , *ESOPHAGEAL fistula , *TREATMENT effectiveness , *ESOPHAGEAL tumors , *ENDOVASCULAR surgery , *BALLOON occlusion , *HEMORRHAGIC shock , *PLASTIC surgery , *HEMOSTASIS , *DISEASE complications - Abstract
Background: Aortoesophageal fistula (AEF) is a rare cause of upper gastrointestinal hemorrhage. Despite diagnostic and therapeutic advances, the mortality rate in AEF patients remains high because of its fulminant course, even with maximal intensive care. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a resuscitation technique to control life-threatening bleeding. It has become an important modality in the management of life-threatening, traumatic or non-traumatic, arterial bleeding. However, it's use in hemorrhagic shock caused by cancer has rarely been reported. Case presentation: A 51-year-old woman with a history of esophageal cancer presented to our emergency department with hematemesis. Computed tomography was performed because of a strong suspicion of hemorrhagic shock. With a diagnosis of AEF due to esophageal cancer, emergency thoracic endovascular aortic repair was performed while the bleeding was controlled using REBOA. Staged elective esophageal reconstruction was successfully performed. Conclusions: Hemostasis is crucial in patients who present with suspected hemorrhagic shock attributable to AEF. The timely implementation of REBOA has shown promise and potential effectiveness in such cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy.
- Author
-
Qi, Jia-Chao, Zhi, Lijia, Li, Huangyu, Huang, Yanping, Ye, Yuming, Li, Hao, Wang, Tiezhu, Lin, Li, and Zhuang, Yuezhen
- Subjects
- *
ESOPHAGEAL fistula , *SQUAMOUS cell carcinoma , *PROPORTIONAL hazards models , *PROGNOSIS , *PLATELET lymphocyte ratio , *NEUTROPHIL lymphocyte ratio - Abstract
Limited studies have focused on the prognostic factors of esophageal respiratory fistula (ERF) associated with radiotherapy in patients with unresectable esophageal squamous cell carcinoma (ESCC). Between January 1st, 2014 and January 1st, 2021, we included patients who were initially diagnosed with unresectable ESCC and underwent radiotherapy. All patients were followed up for a period of 2 years after completing their radiotherapy treatment. The primary outcomes of the study were defined as death or severe adverse events. The survival curves of ERF were calculated using the Kaplan–Meier method. Cox proportional hazards model was employed to calculated the prognostic factors. A cohort of 232 patients underwent radiotherapy, of whom 32 patients experienced ERF. The median period from initial diagnosis of ESCC to ERF was 5.75 months, and the median period from ERF to the primary outcome was 4.6 weeks. Neck + upper chest location (odds ratio [OR] 3.305), high T stage (OR 1.765), esophageal stenosis (OR 1.073), high neutrophil to lymphocyte ratio (NLR) (OR 1.384) and platelet to lymphocyte ratio (PLR) (OR 1.765) were risk factors for the occurrence of ERF. Cox regression analysis suggested that tumor location (hazards ratio [HR] 3.572, 95% confidence interval [CI] 2.467–5.1), high T stage (HR 4.050, 95% CI 2.812–5.831), esophageal stenosis (HR 2.643, 95% CI 1.753–3.983), high PLR (HR 2.541, 95% CI 1.868–3.177) were independent prognostic factors for poor survival. Esophageal stenosis, neck + upper chest tumor location, high T stage and PLR predicted the prognosis of ERF in ESCC patients undergoing radiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy.
- Author
-
Kong, Yue, Su, Miaoyi, Fang, Jun, Chen, Mengyuan, Zheng, Chao, Jiang, Youhua, Tao, Kaiyi, Wang, Changchun, Qiu, Guoqin, Ji, Yongling, Wang, Yuezhen, and Yang, Yang
- Subjects
- *
PACLITAXEL , *SQUAMOUS cell carcinoma , *ESOPHAGEAL fistula , *RADIATION pneumonitis , *IMMUNOTHERAPY , *RADIOTHERAPY - Abstract
With the success of immunotherapy in advanced esophageal cancer, neoadjuvant chemo-immunotherapy (CIT) is being increasingly used for local staged esophageal cancer, especially in the context of clinical trials, which brings similar pCR with neoadjuvant chemoradiotherapy and shows promising results. However, there is still a part of potentially operable patients can't undergo surgery after neoadjuvant chemo-immunotherapy. The follow-up treatment and prognosis of this population remain unclear. Patients pathologically diagnosed with ESCC, clinical stage T1-3N+M0 or T3-4aNanyM0 (AJCC 8th), PS 0–1 were retrospectively enrolled from 1/2020 to 6/2021 in Zhejiang Cancer Hospital. All patients firstly received PD-1 inhibitors plus chemotherapy (albumin paclitaxel, 260 mg/m2 on day 1 plus carboplatin AUC = 5 on day 1) every 3 weeks for 2–4 cycles. For those patients who did not receive surgery, definitive radiotherapy with 50.4 Gy/28F or 50 Gy/25F was adopted using VMAT, concurrent with chemotherapy or alone. The concurrent chemotherapy regimens included weekly TC (paclitaxel 50 mg/m2, d1, carboplatin AUC = 2, d1) or S1 (60 mg bid d1–14, 29–42). The survival outcomes and treatment toxicity were recorded and analyzed. A total of 56 eligible patients were finally identified from 558 patients who were treated in department of thoracic surgery, among all the patients, 25 (44.6%) received radiotherapy alone, and 31 (55.4%) received chemoradiotherapy after neoadjuvant CIT. The median follow-up was 20.4 months (interquartile range [IQR] 8.7–27 months). The median PFS and OS were 17.9 months (95% confidence interval [CI] 11.0–21.9 months) and 20.5 months (95% CI 11.8–27.9 months), respectively. In the subgroup analysis, the median OS was 26.3 months (95% CI 15.33–NA) for patients exhibiting partial response (PR) to CIT, compared to 17 months (95% CI 8.77–26.4) for those with stable disease (SD) or progressive disease (PD), yielding a hazard ratio (HR) of 0.54 (95% CI 0.27–1.06, P = 0.07). No significant difference was observed for patients received radiotherapy alone or chemoradiotherapy with HR = 0.73 (95% CI 0.72–2.6, P = 0.33). The most common Adverse events (AEs) observed during this study were anemia (98.2%), leukopenia (83.9%), thrombocytopenia (53.6%). AEs of grade ≥ 3 radiation-induced pneumonitis and esophagitis were 12.5% and 32.1%, especially, 6 patients (10.7%) died from esophageal fistula and 2 patients (3.6%) died from grade 5 pneumonitis. For local advanced ESCC patients after neoadjuvant CIT who did not receive surgery, definitive radiotherapy was an optional treatment strategy. However, those patients with no response to CIT also showed poor response to radiotherapy, and particular attention should be paid to treatment related toxicity, especially esophageal fistula. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Treatment of lower cervical spine fracture with ankylosing spondylitis by simple long anterior cervical plate: a retrospective study of 17 cases.
- Author
-
Weifu Chen, Yu Yang, Wenjun Pan, Xinhuan Lei, Zhenghua Hong, and Hua Luo
- Subjects
VERTEBRAL fractures ,CERVICAL vertebrae ,ANKYLOSING spondylitis ,ESOPHAGEAL fistula ,AUTOIMMUNE diseases ,SPINAL nerves ,CLINICAL deterioration - Abstract
Objective: Ankylosing spondylitis (AS), an autoimmune disease, often leads to lower cervical spine fractures, with the potential for severe spinal nerve damage even from low-energy injuries. The optimal treatment approach remains debated. Methods: A retrospective study involved 17 AS patients with lower cervical spine fractures who received anterior cervical fixation. Most presented cervicothoracic or thoracolumbar kyphosis, with 11 exhibiting neurological deficits. Patient characteristics, clinical data, visual analog scale (VAS), complications, and nerve recovery were analyzed. Results: No postoperative neurological deterioration occurred. All cases experienced complete fusion of fractures during the follow-up period. Preoperative VAS significantly decreased at 3 days and 3 months post-surgery. Of the 11 patients with preoperative neurological deficits, approximately 54.5% showed improvement post-surgery. No complications were reported, such as esophageal fistula, wound infection, or fixation failure. Conclusion: Anterior internal fixation is a possible treatment for AS-related lower cervical fractures. This approach ensures satisfactory spinal stability and neurological recovery with proper cranial traction and external fixation post-surgery. Our findings demonstrate that this surgical method is safe and effective. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. The characteristics of eating, drinking and oro-pharyngeal swallowing difficulties associated with repaired oesophageal atresia/tracheo-oesophageal fistula: a systematic review and meta-proportional analysis.
- Author
-
Stewart, Alexandra, Govender, Roganie, Eaton, Simon, Smith, Christina H., De Coppi, Paolo, and Wray, Jo
- Subjects
- *
ESOPHAGEAL fistula , *DEGLUTITION , *INGESTION , *SCIENCE databases , *WEB databases - Abstract
Introduction: Eating, drinking and swallowing difficulties are commonly reported morbidities for individuals born with OA/TOF. This study aimed to determine the nature and prevalence of eating, drinking and oro-pharyngeal swallowing difficulties reported in this population. Method: A systematic review and meta-proportional analysis were conducted (PROSPERO: CRD42020207263). MEDLINE, EMBASE, CINAHL, Pubmed, Scopus, Web of Science databases and grey literature were searched. Quantitative and qualitative data were extracted relating to swallow impairment, use of mealtime adaptations and eating and drinking-related quality of life. Quantitative data were summarised using narrative and meta-proportional analysis methods. Qualitative data were synthesised using a meta-aggregation approach. Where quantitative and qualitative data described the same phenomenon, a convergent segregated approach was used to synthesise data. Results: Sixty-five studies were included. Six oro-pharyngeal swallow characteristics were identified, and pooled prevalence calculated: aspiration (24%), laryngeal penetration (6%), oral stage dysfunction (11%), pharyngeal residue (13%), nasal regurgitation (7%), delayed swallow initiation (31%). Four patient-reported eating/drinking difficulties were identified, and pooled prevalence calculated: difficulty swallowing solids (45%), difficulty swallowing liquids (6%), odynophagia (30%), coughing when eating (38%). Three patient-reported mealtime adaptations were identified, and pooled prevalence calculated: need for water when eating (49%), eating slowly (37%), modifying textures (28%). Mixed methods synthesis of psychosocial impacts identified 34% of parents experienced mealtime anxiety and 25% report challenging mealtime behaviours reflected in five qualitative themes: fear and trauma associated with eating and drinking, isolation and a lack of support, being aware and grateful, support to cope and loss. Conclusions: Eating and drinking difficulties are common in adults and children with repaired OA/TOF. Oro-pharyngeal swallowing difficulties may be more prevalent than previously reported. Eating, drinking and swallowing difficulties can impact on psychological well-being and quality of life, for the individual and parents/family members. Long-term, multi-disciplinary follow-up is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Cryoballoon-Assisted Pulmonary Vein Isolation and Left Atrial Roof Ablation Using a Simplified Sedation Strategy without Esophageal Temperature Monitoring: No Notable Thermal Esophageal Lesions and Low Arrhythmia Recurrence Rates after 2 Years.
- Author
-
Erkapic, Damir, Roussopoulos, Konstantinos, Aleksic, Marko, Sözener, Korkut, Kostev, Karel, Rosenbauer, Josef, Sossalla, Samuel, Gündüz, Dursun, Labenz, Joachim, Tanislav, Christian, and Weipert, Kay Felix
- Subjects
- *
PULMONARY veins , *ESOPHAGEAL fistula , *LEFT heart atrium , *ATRIAL fibrillation , *ARRHYTHMIA , *CRYOSURGERY - Abstract
Background: Atrial fibrillation (AF) ablation is increasingly effective for managing heart rhythm but poses risks like esophageal fistulas. Minimizing esophageal thermal lesions while simplifying procedures is crucial. Methods: This prospective study involved 100 consecutive AF patients undergoing cryoballoon ablation with simplified sedation, without esophageal temperature monitoring. Patients with paroxysmal AF (Group A) received pulmonary vein isolation only, while those with persistent AF (Group B) also had left atrial roof ablation. Gastroesophageal endoscopy was performed post-procedure to detect lesions, and cardiological follow-ups were conducted at 3, 12, and 24 months. Results: The cohort included 69% men, with a median age of 65.5 years. Post-ablation endoscopy was performed in 92 patients; esophageal lesions were found in 1.1% of Group A and none of Group B. GERD was diagnosed in 14% of patients, evenly distributed between groups and not linked to lesion occurrence. Gastric hypomotility was observed in 16% of patients, with no significant difference between groups. At 24 months, arrhythmia-free survival was 88% in Group A and 74% in Group B. Conclusion: Cryoballoon-assisted pulmonary vein isolation, with or without additional left atrial roof ablation and without esophageal temperature monitoring during a simplified sedation strategy, shows low risk of esophageal thermal injury and effective ablation outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Aortoesophageal Fistula Mimicking Dieulafoy Disease: A Case Report
- Author
-
Tatiana Pacheco, Pedro Costa-Moreira, Sara Monteiro, Joana Pinto, Luísa Barros, and Jorge Silva
- Subjects
esophageal fistula ,aortic diseases ,gastrointestinal bleeding ,computed tomography angiography ,aged 80 and over ,fístula esofágica ,doenças da aorta ,hemorragia gastrointestinal ,angiografia por tomografia computadorizada ,idosos, 80 anos ou mais ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introduction: Aortoesophageal fistula (AEF) is a rare and potentially fatal cause of upper gastrointestinal bleeding. The classic Chiari’s triad of symptoms and typical endoscopic findings are not present in all patients, making diagnosis challenging. Case Presentation: An 86-year-old man was admitted to the emergency room for melena and hematemesis with hemodynamic instability. He had a previous hospitalization for cardioembolic stroke complicated by hematemesis of unknown etiology after initiation of anticoagulation (which was suspended), being discharged on aspirin. His medical history also included hypertension, diabetes, ischemic heart disease, and prostate cancer. On upper endoscopy, no lesions were found, despite the presence of a large non-mobilizable clot in the gastric fundus. He was admitted to the intensive care unit, and, on the next day, reassessment esophagogastroduodenoscopy was normal. On the eighth day of hospitalization, the patient presented with hemorrhagic shock due to new-onset hematemesis. Upper endoscopy revealed an esophageal 10-mm non-ulcerated mucosal depression with a visible vessel at 20 cm from the incisors, closed with 3 hemoclips. Thoracic CT angiography showed a brachiocephalic trunk aneurysm with aortoesophageal fistulization. He was deemed unsuitable for endovascular or surgical treatment. About 2 months later, the patient was admitted to the emergency room in cardiorespiratory arrest following an episode of hematemesis at home. Discussion: This report highlights the diagnostic and therapeutic complexity of AEF. Endoscopic treatment can be the main therapy in patients without indication for vascular intervention. The purpose was to palliate new bleeding episodes, maintaining a very poor prognosis.
- Published
- 2024
- Full Text
- View/download PDF
11. Endoscopic Management of Esophageal Wall Defects
- Author
-
Mohammad Al-Haddad, Associate Professor of Medicine
- Published
- 2023
12. Esophageal and gastric pythiosis in a dog.
- Author
-
Sousa da Silva, Emanoelly Machado, Fernandes Martins, Kamila Peruchi, Barbosa Pereira, Asheley Henrique, Hentz Gris, Anderson, Harumi Maruyama, Fernanda, Nakazato, Luciano, Moleta Colodel, Edson, Schneider de Oliveira, Luiz Gustavo, and Marques Boabaid, Fabiana
- Subjects
- *
GASTROINTESTINAL system , *ESOPHAGEAL fistula , *DOGS , *DOG diseases , *GASTROINTESTINAL diseases , *GRANULATION tissue , *AUTOPSY - Abstract
Pythiosis is the disease caused by aquatic oomycetes of the genus Pythium. In dogs the typical course of the disease involves the gastrointestinal tract, characterized by transmural thickening of the stomach or intestines. However, infection by Pythium spp. has only rarely been recognized as a cause of esophagitis in dogs. Thus, the present reports a case of esophageal and gastric pythiosis in an eight-month-old female pit bull dog. The dog was attended at the hospital after two months presenting regurgitation and dyspnea. It was reported that the dog lived in an urban area and had no previous sanitary issues. At clinical examination it was noted that the dog presented crackling sounds at pulmonary auscultation. A support therapy accompanied by antibiotics has been employed; however, 22 days after hospitalization the clinical condition worsened, and the dog died. At necropsy, the wall of the distal segment of the esophagus and the cardia and part of the fundus of the stomach were expanded by a focal extensive irregular intramural annular mass. Additionally, there was a transmural esophageal fistula. At histology, the walls of the esophagus and stomach were extensively expanded by multifocal extensive areas of necrosis, associated with a pyogranulomatous infiltrate and abundant granulation tissue containing multiple negative images of hyphae that were highlighted by silver impregnation (Grocott). Furthermore, immunohistochemistry and PCR for P. insidiosum were both positive in samples of paraffin-embedded esophageal tissue. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Oesophago-pericardial fistula after catheter ablation of atrial fibrillation: a case report.
- Author
-
Wu, Shaohui, Zou, Guangchen, Sun, Yuzhang, Jiang, Weifeng, and Liu, Xu
- Subjects
CATHETER ablation ,ATRIAL fibrillation ,ESOPHAGEAL fistula ,FISTULA ,MEDICAL drainage ,CHEST pain ,COMPUTED tomography - Abstract
Background Oesophageal fistula is a rare complication of catheter ablation of atrial fibrillation with most fistulas being atrio-oesophageal fistulas, but oesophageal–pericardial fistula can also happen in the absence of atrial perforation. Case summary A 68-year-old male patient presented with chest pain 10 days after catheter ablation of paroxysmal atrial fibrillation. He was discharged after an initial negative workup that included a CT chest without contrast. He later presented again with severe chest pain and fever and was found to have an oesophageal–pericardial fistula. He underwent surgical and endoscopic treatment with good recovery. Discussion Patients with oesophago-pericardial fistulas often have delayed presentation 1–4 weeks after the ablation procedure. Early diagnosis can be challenging. CT with oral and intravenous contrast is often used for diagnosis. Treatment often includes antibiotics, surgical or interventional drainage of infected spaces with oesophageal repair, clipping or stenting. In contrast to atrio-oesophageal fistulas that carry a high mortality rate, mortality for oesophago-pericardial fistulas appears to be much lower. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Aortoesophageal fistula due to esophageal cancer: a case report of successful management.
- Author
-
Saisho, Kohei, Mori, Naoki, Nakagawa, Masashi, Nakamura, Eiji, Tanaka, Yu, Kaku, Hideaki, Tanaka, Yuya, Isobe, Taro, Otsuka, Hiroyuki, Sudo, Tomoya, Sakai, Hisamune, Ishibashi, Nobuya, Hisaka, Toru, Tayama, Eiki, and Fujita, Fumihiko
- Subjects
ESOPHAGEAL cancer ,ESOPHAGEAL fistula ,ENDOVASCULAR aneurysm repair ,THORACIC aorta ,ESOPHAGEAL tumors ,LOSS of consciousness - Abstract
Background: Aortoesophageal fistula (AEF) is a rare but potentially life-threatening condition. The best treatment for the AEF due to esophageal carcinoma is still unresolved. Here, we report a rare case of AEF caused by esophageal cancer, that was successfully treated with emergency thoracic endovascular aortic repair (TEVAR), followed by esophagectomy and gastric tube reconstruction. Case presentation: A 64-year-old man presented with loss of consciousness and hypotension during chemoradiotherapy for advanced esophageal cancer. Enhanced computed tomography showed extravasation from the descending aorta into the esophagus at the tumor site. We performed emergency TEVAR for the AEF, which stabilized the hemodynamics. We then performed thoracoscopic subtotal esophagectomy on day 4 after TEVAR to prevent graft infection, followed by gastric tube reconstruction on day 30 after TEVAR. At 9 months after the onset of AEF, the patient continues to receive outpatient chemotherapy and leads a normal daily life. Conclusion: TEVAR is a useful hemostatic procedure for AEF. If the patient is in good condition and can continue treatment for esophageal cancer, esophagectomy and reconstruction after TEVAR should be performed to prevent graft infection and maintain quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram.
- Author
-
Zhu, Chao, Sun, Wenju, Chen, Cunhai, Qiu, Qingtao, Wang, Shuai, Song, Yang, and Ma, Xuezhen
- Subjects
ESOPHAGEAL fistula ,NOMOGRAPHY (Mathematics) ,LOGISTIC regression analysis ,FEATURE extraction ,PANCREATIC fistula ,FEATURE selection ,ESOPHAGEAL cancer - Abstract
Background: Malignant esophageal fistula (MEF), which occurs in 5% to 15% of esophageal cancer (EC) patients, has a poor prognosis. Accurate identification of esophageal cancer patients at high risk of MEF is challenging. The goal of this study was to build and validate a model to predict the occurrence of esophageal fistula in EC patients. Methods: This study retrospectively enrolled 122 esophageal cancer patients treated by chemotherapy or chemoradiotherapy (53 with fistula, 69 without), and all patients were randomly assigned to a training (n = 86) and a validation (n = 36) cohort. Radiomic features were extracted from pre-treatment CTs, clinically predictors were identified by logistic regression analysis. Lasso regression model was used for feature selection, and radiomics signature building. Multivariable logistic regression analysis was used to develop the clinical nomogram, radiomics-clinical nomogram and radiomics prediction model. The models were validated and compared by discrimination, calibration, reclassification, and clinical benefit. Results: The radiomic signature consisting of ten selected features, was significantly associated with esophageal fistula (P = 0.001). Radiomics-clinical nomogram was created by two predictors including radiomics signature and stenosis, which was identified by logistic regression analysis. The model showed good discrimination with an AUC = 0.782 (95% CI 0.684–0.8796) in the training set and 0.867 (95% CI 0.7461–0.987) in the validation set, with an AIC = 101.1, and good calibration. When compared to the clinical prediction model, the radiomics-clinical nomogram improved NRI by 0.236 (95% CI 0.153, 0.614) and IDI by 0.125 (95% CI 0.040, 0.210), P = 0.004. Conclusion: We developed and validated the first radiomics-clinical nomogram for malignant esophageal fistula, which could assist clinicians in identifying patients at high risk of MEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. A Successful Treatment of Broncho-Esophageal Fistula with Esophageal Stenting Using Direct Endoscopic Visualization.
- Author
-
Banciu, Christian, Aprotosoaie, Adrian, Vancea, Dorin, Taban, Sorina, Guse, Cristina, Budu, Oana, Fabian, Ramona, Chiriac, Sorin, Căruntu, Florina, and Voicu, Adrian
- Subjects
ESOPHAGEAL fistula ,TREATMENT effectiveness ,DATA visualization ,COMPUTED tomography ,PALLIATIVE treatment ,FISTULA ,BRONCHIAL fistula - Abstract
Broncho-esophageal fistula (BEF) is a severe yet relatively rare connection between the bronchus and esophagus usually caused by esophageal and pulmonary malignancies. We present a case report of a 49-year-old man diagnosed with terminal lung carcinoma who developed a BEF. The thoracic computed tomography scan detected a mass in the left bronchi that partially covers and disrupts the bronchial contour in certain regions and extends to the esophageal wall. After thoroughly evaluating alternative treatment approaches, we opt for the stenting procedure due to the advanced stage of the tumor and the significantly diminished quality of life. The treatment involves the use of a partially covered metal stent that is known to exhibit lower potential to migrate. The treatment is highly successful, resulting in a significant enhancement of the patient's quality of life, a lengthening in his survival, and the ability to pursue additional palliative treatment options. In contrast to the typical prosthesis implantation, our procedure uses a direct endoscopic visualization for the proximal deployment of a partially covered stent, offering a cost-effective and radiation-free alternative that can be particularly beneficial for BEF patients in facilities without radiology services. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Azygos Vein Preservation; Its Impact on Early Outcomes After Neonatal EA/TOF Repair (EArAzygousvp)
- Author
-
dr. Muhammad Abdelhafez Mahmoud, MD, Lecturer of pediatric surgery, Al-Azhar Faculty of Medicine
- Published
- 2023
18. Oesophageal Protection Study: A Multicentre Study. (IMPACT II)
- Author
-
St. George's Hospital, London, University of Pennsylvania, National Health Service, United Kingdom, Berry Consultants, Virginia Commonwealth University, University of Colorado, Denver, Texas Cardiac Arrhythmia Research Foundation, Beth Israel Deaconess Medical Center, Royal Brompton & Harefield NHS Foundation Trust, The Queen Elizabeth Hospital, and Guy's and St Thomas' NHS Foundation Trust
- Published
- 2023
19. Outcome Predictors of Trachea-esophageal Fistula
- Author
-
Assem Abd El-razek Elkateeb, Doctor
- Published
- 2023
20. Vascular covered stent and video-assisted thoracoscopic surgery for Aortoesophageal fistula caused by esophageal fishbone: a case report.
- Author
-
Chen, Jianfeng
- Subjects
- *
VIDEO-assisted thoracic surgery , *ESOPHAGEAL fistula , *ENDOVASCULAR aneurysm repair , *THORACIC surgery , *AORTIC rupture , *THERAPEUTICS , *HOSPITAL admission & discharge - Abstract
Background: Aortoesophageal fistula (AEF) is a rare condition characterized by communication between the aorta and esophagus. AEF caused by an esophageal foreign body is even rare, and there is currently no recommended standard treatment protocol. We report a case of delayed aortic rupture after the endoscopic removal of a fish bone, which was successfully treated with a combined approach of vascular stenting and thoracic surgery. Case presentation: A 33-year-old man presented to the hospital after experiencing chest discomfort for 3 days following the accidental ingestion of a fish bone. Under endoscopic guidance, the fish bone was successfully removed, and the patient was subsequently admitted for medical therapy. On the fourth postoperative day, the patient suddenly developed hematemesis, and chest computed tomography angiography revealed the presence of an AEF. This necessitated urgent intervention; hence, thoracic surgery was performed and a vascular-covered stent was placed. Following the surgical procedure, the patient received active medical treatment, recovered well, and was successfully discharged from the hospital. Conclusions: In patients with esophageal perforation caused by foreign bodies, hospitalization for observation, computed tomography angiography examination, early use of antibiotics, and careful assessment of aortic damage are advised. Thoracic endovascular aortic repair and esophageal rupture repair may have benefits for the treatment of AEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Novel Prediction Score for Arterial–Esophageal Fistula in Patients with Esophageal Cancer Bleeding: A Multicenter Study.
- Author
-
Lu, Sz-Wei, Niu, Kuang-Yu, Pai, Chu-Pin, Lin, Shih-Hua, Chen, Chen-Bin, Lo, Yu-Tai, Lee, Yi-Chih, Seak, Chen-June, and Yen, Chieh-Ching
- Subjects
- *
RESEARCH , *ESOPHAGEAL fistula , *SCIENTIFIC observation , *CONFIDENCE intervals , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *RESEARCH funding , *PREDICTION models , *LOGISTIC regression analysis , *ODDS ratio , *ESOPHAGEAL tumors , *HEMORRHAGE , *LONGITUDINAL method - Abstract
Simple Summary: In patients with esophageal cancer bleeding, the presence of tumor ulcer and arterial–esophageal fistula (AEF) is a common occurrence. Notably, AEF is associated with an exceptionally poor prognosis, yet there is no prediction score to estimate its occurrence rate. Therefore, we introduce a novel model, the HEARTS-Score, for predicting AEF in esophageal cancer bleeding patients. This predictive model effectively distinguishes patients at risk, as evidenced by a c-statistic of 0.82 (95% CI 0.72–0.92). By employing this model, clinicians can more objectively differentiate between high-risk and low-risk patients, facilitating more efficient clinical decision-making, diagnostic planning, and subsequent treatment strategies. Purpose: To develop and internally validate a novel prediction score to predict the occurrence of arterial–esophageal fistula (AEF) in esophageal cancer bleeding. Methods: This retrospective cohort study enrolled patients with esophageal cancer bleeding in the emergency department. The primary outcome was the diagnosis of AEF. The patients were randomly divided into a derivation group and a validation group. In the derivation stage, a predictive model was developed using logistic regression analysis. Subsequently, internal validation of the model was conducted in the validation cohort during the validation stage to assess its discrimination ability. Results: A total of 257 patients were enrolled in this study. All participants were randomized to a derivation cohort (n = 155) and a validation cohort (n = 102). AEF occurred in 22 patients (14.2%) in the derivation group and 14 patients (13.7%) in the validation group. A predictive model (HEARTS-Score) comprising five variables (hematemesis, active bleeding, serum creatinine level >1.2 mg/dL, prothrombin time >13 s, and previous stent implantation) was established. The HEARTS-Score demonstrated a high discriminative ability in both the derivation and validation cohorts, with c-statistics of 0.90 (95% CI 0.82–0.98) and 0.82 (95% CI 0.72–0.92), respectively. Conclusions: By employing this novel prediction score, clinicians can make more objective risk assessments, optimizing diagnostic strategies and tailoring treatment approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomy.
- Author
-
Geng, Xiang, Zhao, Qing, Yuan, Hang, Li, Hai-Liang, Guo, Chen-Yang, Yang, Ting, Fan, Wei-Jun, Park, Jung-Hoon, Zhao, Xiao-Hui, Zhu, Wen-Bo, and Hu, Hong-Tao
- Subjects
- *
ESOPHAGEAL cancer , *GASTROSTOMY , *COMPUTED tomography , *PERCUTANEOUS endoscopic gastrostomy , *ESOPHAGEAL fistula , *CANCER patients , *FLUOROSCOPY - Abstract
Purpose: To explore the value of clinical application with the whole process computed tomography (CT) guided percutaneous gastrostomy in esophageal tumor patients. Materials and methods: A consecutive series of 32 esophageal tumor patients in whom endoscopic gastrostomy or fluoroscopy guided gastrostomy were considered too dangerous or impossible due to the esophagus complete obstruction, complicate esophageal mediastinal fistula, esophageal trachea fistula or severe heart disease. All of the 32 patients were included in this study from 2 medical center and underwent the gastrostomy under whole process CT guided. Results: All of the gastrostomy procedure was finished successfully under whole process CT guided and the technical success rate was 100%. The average time for each operation was 27 min. No serious complications occurred and the minor complications occurred in 3 patients, including local infection, severe hyperplasia of granulation tissue and tube dislodgment. There were no procedure related deaths. Conclusion: The technical success rate of whole process CT guided percutaneous gastrostomy is high and the complication is low. This technique can be used feasible and effectively in some special patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Perceptual Assessment of the Tracheoesophageal Voice
- Author
-
D'Alatri Lucia, Prof
- Published
- 2023
24. Use of Indocyanine Green During Primary Repair of Oesophageal Atresia and Distal Tracheo-oesophageal Fistula (iTOF)
- Published
- 2023
25. Platelet-rich plasma therapy for postoperative esophageal fistula in a pediatric patient.
- Author
-
Mitri, Marco Di, Chiastra, Greta, Collautti, Edoardo, D'Antonio, Simone, Buzzi, Marina, Bisanti, Cristian, Carmine, Annalisa Di, Catania, Vincenzo, Libri, Michele, Gargano, Tommaso, and Lima, Mario
- Subjects
- *
ESOPHAGEAL fistula , *CHILD patients , *PLATELET-rich plasma , *CORD blood , *UMBILICAL cord clamping , *POSTOPERATIVE care ,ESOPHAGEAL atresia - Abstract
Postoperative management of esophagocutaneous fistulas in pediatric patients is challenging, often resulting in prolonged hospitalization and increased morbidity. Platelet-rich plasma (PRP) has emerged as a promising adjunctive treatment for such complications. We present the case of a 7-month-old infant who developed an esophago-cutaneous fistula following esophagocoloplasty for esophageal atresia type A. Despite initial conservative management, the fistula persisted, prompting the application of PRP gel derived from umbilical cord blood. After four applications of PRP, complete closure of the fistula was achieved, leading to both functional and aesthetic results. This case highlights the potential of PRP in managing refractory postoperative esophageal fistulas in pediatric patients and underscores the need for further research to optimize treatment protocols and validate its efficacy for this sort of complications [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. A Rare Cause of Upper Gastrointestinal Bleeding: Aorta-Esophageal Fistula.
- Author
-
Ölmez, Şehmus, Cereb, Ferid, Çelikdemir, Ayşe Yıldırım, Çapar, Halil, Çetin, Duran Deha, and Sarıtaş, Bünyamin
- Subjects
GASTROINTESTINAL hemorrhage ,ESOPHAGEAL fistula ,AORTIC aneurysms ,TREATMENT effectiveness ,THORACIC surgery - Abstract
Aortoesophageal fistula (AEF) is rarely seen in gastroenterology practice. It is a very fatal condition. Common causes of AEF are aortic aneurysms and dissections, foreign body ingestion, traumatic aortic injuries, ruptured penetrating aortic ulcers, esophageal or bronchogenic malignancies, and thoracic surgery such as thoracic endovascular aortic repair (TEVAR). Post-TEVAR AEF is a very rare cause of massive upper gastrointestinal bleeding (UGIB). Management of AEF is difficult and causes serious outcomes. Here we report a case presented with UGIB related to post-TEVAR AEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer
- Author
-
Iatagan R. Josino, Bruno C. Martins, Andressa A. Machado, Gustavo R. de A. Lima, Martin A. C. Cordero, Amanda A. M. Pombo, Rubens A. A. Sallum, Ulysses Ribeiro Jr, Todd H. Baron, and Fauze Maluf-Filho
- Subjects
esophageal fistula ,esophageal neoplasms ,self-expandable metallic stents ,Internal medicine ,RC31-1245 ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background/Aims Self-expandable metallic stents (SEMSs) are widely adopted for the palliation of dysphagia in patients with malignant esophageal strictures. An important adverse event is the development of SEMS-induced esophagorespiratory fistulas (SEMS-ERFs). This study aimed to assess the risk factors related to the development of SEMS-ERF after SEMS placement in patients with esophageal cancer. Methods This retrospective study was performed at the Instituto do Cancer do Estado de São Paulo. All patients with malignant esophageal strictures who underwent esophageal SEMS placement between 2009 and 2019 were included in the study. Results Of the 335 patients, 37 (11.0%) developed SEMS-ERF, with a median time of 129 days after SEMS placement. Stent flare of 28 mm (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.15–5.51; p=0.02) and post-stent chemotherapy (HR, 2.0; 95% CI, 1.01–4.00; p=0.05) were associated with an increased risk of developing SEMS-ERF, while lower-third tumors were a protective factor (HR, 0.5; 95% CI, 0.26–0.85; p=0.01). No difference was observed in overall survival. Conclusions The incidence of SEMS-ERFs was 11%, with a median time of 129 days after SEMS placement. Post-stent chemotherapy and a 28 mm stent flare were associated with a higher risk of SEMS-ERF.
- Published
- 2023
- Full Text
- View/download PDF
28. Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer.
- Author
-
Josino, Iatagan R., Martins, Bruno C., Machado, Andressa A., de A. Lima, Gustavo R., Cordero, Martin A. C., Pombo, Amanda A. M., Sallum, Rubens A. A., Ribeiro Jr, Ulysses, Baron, Todd H., and Maluf-Filho, Fauze
- Subjects
- *
CANCER patients , *ESOPHAGEAL cancer , *FISTULA , *ESOPHAGEAL fistula , *OVERALL survival , *CONFIDENCE intervals - Abstract
Background/Aims: Self-expandable metallic stents (SEMSs) are widely adopted for the palliation of dysphagia in patients with malignant esophageal strictures. An important adverse event is the development of SEMS-induced esophagorespiratory fistulas (SEMSERFs). This study aimed to assess the risk factors related to the development of SEMS-ERF after SEMS placement in patients with esophageal cancer. Methods: This retrospective study was performed at the Instituto do Cancer do Estado de São Paulo. All patients with malignant esophageal strictures who underwent esophageal SEMS placement between 2009 and 2019 were included in the study. Results: Of the 335 patients, 37 (11.0%) developed SEMS-ERF, with a median time of 129 days after SEMS placement. Stent flare of 28 mm (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.15-5.51; p=0.02) and post-stent chemotherapy (HR, 2.0; 95% CI, 1.01-4.00; p=0.05) were associated with an increased risk of developing SEMS-ERF, while lower-third tumors were a protective factor (HR, 0.5; 95% CI, 0.26-0.85; p=0.01). No difference was observed in overall survival. Conclusions: The incidence of SEMS-ERFs was 11%, with a median time of 129 days after SEMS placement. Post-stent chemotherapy and a 28 mm stent flare were associated with a higher risk of SEMS-ERF. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Removal of the Evolution® Esophageal Stent - Fully Covered (CLARITY)
- Published
- 2022
30. Inverse Ratio Ventilation in Neonatal Open Repair of Tracheoesophageal Fistula.
- Author
-
Akram Mohamed Mohamed Amer, Lecturer in the department of Anesthesia
- Published
- 2022
31. Chronic esophageal fistula as a rare cause of secondary osteomyelitis of the thoracic spine
- Author
-
Valeriya A. Zarya, Pavel V. Gavrilov, Marina E. Makogonova, Andrey R. Kozak, and Arkadiy A. Vishnevskiy
- Subjects
osteomyelitis ,spondylitis ,esophageal fistula ,Computer applications to medicine. Medical informatics ,R858-859.7 - Abstract
Infectious diseases affecting the spine are inflammatory destructive diseases that involved the organ and its structural elements as a result of infection by hematogenic, lymphogenic, or contact pathways, including may be a complication of surgical intervention. In arriving at an accurate diagnosis, it is extremely important to evaluate the anamnesis, the clinical picture, as well as the data of laboratory studies and radiation diagnostics in the aggregate. This article presents a clinical case with the development of secondary ThVII–ThVIII vertebral spondylitis due to esophageal fistula. At the initial diagnosis, spondylitis was associated with spinal anesthesia performed six months prior to onset of the disease, as there was a fistulous defect on the skin in the lumbar region. Consequently, surgical interventions were performed three times in a surgical hospital at the place of residence. The data from the endoscopic examination, as well as the patient’s complaints regarding the relationship between meals, the appearance of pain, and the nature of the discharge from the fistula were not taken into account by doctors initially. With the help of an additional examination, including computed tomography of the esophagus with oral contrast and computed tomography fistulography, the main diagnosis was esophageal fistula. Thoracic spondylitis was only a secondary complication. Thus, the final diagnosis of back pain and fistula in the lumbar region should be formulated after differential diagnosis with alternative diseases of the spine.
- Published
- 2023
- Full Text
- View/download PDF
32. PrOgnosis Following Esophageal fisTula formaTion in Pts Undergoing cathetER Ablation for AF Study (POTTER)
- Author
-
Dr.Ahmad Keelani and Prof. Roland Richard Tilz, Prof. Dr. med. Roland Richard Tilz
- Published
- 2022
33. Swallowing, Feeding and Eating in Children Born With Oesophageal Atresia/Trache-oesophageal Fistula (OA/TOF) (SaFE)
- Author
-
National Institute for Health Research, United Kingdom
- Published
- 2022
34. Open or Keyhole Surgery Through the Chest for Newborn Babies: Effect on Blood Gases (CO2)
- Published
- 2022
35. Conservative endoscopic closure with fibrin glue of an aorto-esophageal fistula secondary to endovascular repair of a contained penetrating atherosclerotic ulcer rupture
- Author
-
Nancy Halloum, MD, Mahmoud Abdalhafez, MD, Florian Thieringer, MD, Daniel Grimm, MD, Hendrik Treede, MD, PhD, and Hazem El Beyrouti, MD, PhD
- Subjects
Aorta ,Aortic ulcer ,Endoscopy ,Endovascular procedures ,Esophageal fistula ,Esophagus vacuum therapy ,Surgery ,RD1-811 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
An aorto-esophageal fistula (AEF) is a rare complication of aortic surgery but can cause potentially lethal upper gastrointestinal tract bleeding. A patient presented with an AEF secondary to emergency endovascular repair of a contained penetrating atherosclerotic ulcer rupture of the thoracic aorta and was successfully treated with endoscopic closure using fibrin glue. As endovascular repair becomes increasingly common, a greater incidence of AEFs should be anticipated and the treatment options better described.
- Published
- 2023
- Full Text
- View/download PDF
36. Retrospective analysis of 10 cases with esophageal fistula after anterior surgery for cervical spine fracture
- Author
-
Jinpeng Du, Xiangcheng Gao, Dingjun Hao, Zhengxue Quan, Liang Yan, and Baorong He
- Subjects
Anterior surgery ,Complication ,Esophageal fistula ,Spine fracture ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Objective: This study aims to discuss the appropriate treatment of esophageal fistula following anterior surgery for cervical spine fracture. Methods: Clinical data of patients with cervical spine fracture treated at our research center from January 2000 to December 2019 were screened. Data of patients with esophageal fistula were included, and the causes of injury, diagnosis, and treatment were retrospectively analyzed. Results: A total of 3578 patients with cervical spine fracture were screened, among whom there were 10 cases (0.28 %) of esophageal fistula. 60 % of the cases were early-onset and all were caused by intraoperative electric knife injury. The positive rate of early endoscopy was only 25 %, while routine radiography showed a positive rate of 33.3 % after three attempts. Among the six patients with early-onset esophageal fistula, three underwent sternocleidomastoid flap transfer and two underwent primary suture, all achieving successful healing. In the four cases of late-onset esophageal fistula, two patients received implant removal, debridement, incision lavage, and sternocleidomastoid muscle flap transfer three weeks later. One patient received implant removal, debridement, vacuum sealing drainage, followed by sternocleidomastoid muscle pedicle transfer muscle flap plus lavage two weeks later and achieved complete recovery. All patients gargled alternately with metronidazole and chlorhexidine gargle after surgery. Conclusion: The occurrence of esophageal fistula is associated with surgical procedures, esophageal injury, and implant compression. Esophagography and endoscopy are the primary diagnostic methods, while incision exploration after ingestion of food mixed with methylene serves as a supplementary approach. Recommended treatments include alternating metronidazole and chlorhexidine gargles, esophageal rest, repair of the fistula, muscle flap packing, lavage and drainage, nutritional support, and removal of internal fixation if necessary. Post-surgery administration of antibiotics should continue until three consecutive lavage cultures yield negative results.
- Published
- 2023
- Full Text
- View/download PDF
37. Efficacy and Safety of Self-Expandable Metallic Stent Placement for Malignant Esophageal Fistula.
- Author
-
Izumi, Atsuko, Yoshio, Toshiyuki, Sasaki, Takashi, Ishioka, Mitsuaki, Kizawa, Atsuko, Ikenoyama, Yohei, Namikawa, Ken, Tokai, Yoshitaka, Yoshimizu, Shoichi, Horiuchi, Yusuke, Ishiyama, Akiyoshi, Hirasawa, Toshiaki, Chin, Keisho, Ogura, Mariko, Sasahira, Naoki, and Fujisaki, Junko
- Subjects
- *
ESOPHAGEAL fistula , *PALLIATIVE treatment , *SURVIVAL rate , *CANCER hospitals , *ESOPHAGEAL cancer , *FISTULA , *BRONCHIAL fistula , *CHEMORADIOTHERAPY - Abstract
Patients with malignant esophageal fistulas often experience dysphagia and infection, resulting in poor prognoses. Self-expandable metallic stent (SEMS) placement is a palliative treatment option; however, its efficacy and safety are unclear. We aimed to determine the efficacy and safety of SEMS placement for malignant esophageal fistulas. We retrospectively investigated patients who underwent SEMS placement for malignant esophageal fistulas between 2013 and 2022 at the Cancer Institute Hospital. Dysphagia scores (DSs) before and after SEMS placement, adverse events, and overall survival from SEMS placement until death were evaluated. A total of 17 patients underwent SEMS placement, including 12 and 5 patients with esophageal and lung cancers, respectively. Prior treatments included chemoradiotherapy (n = 11), radiotherapy (n = 4), and chemotherapy (n = 4); two patients underwent palliative radiotherapy after chemotherapy. All procedures were technically successful. After SEMS placement, 14 (82.4%) patients were able to consume semisolid or solid food (DS ≤ 2). Major adverse events were encountered in only one case. The median survival time after SEMS placement was 71 days (range 17–247 days). SEMS placement allowed most patients to resume oral intake with a low rate of major adverse events. SEMS placement is a reasonable palliative treatment option for patients with malignant fistulas who have poor prognoses. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study.
- Author
-
Tilz, Roland Richard, Schmidt, Vanessa, Pürerfellner, Helmut, Maury, Philippe, Chun, K R J ulian, Martinek, Martin, Sohns, Christian, Schmidt, Boris, Mandel, Franck, Gandjbakhch, Estelle, Laredo, Mikael, Gunawardene, Melanie Anuscha, Willems, Stephan, Beiert, Thomas, Borlich, Martin, Iden, Leon, Füting, Anna, Spittler, Raphael, Gaspar, Thomas, and Richter, Sergio
- Subjects
ESOPHAGEAL fistula ,CATHETER ablation ,ATRIAL fibrillation ,ATRIAL flutter ,PROGNOSIS ,CONSERVATIVE treatment - Abstract
Aims Oesophageal fistula represents a rare but dreadful complication of atrial fibrillation catheter ablation. Data on its incidence, management, and outcome are sparse. Methods and results This international multicentre registry investigates the characteristics of oesophageal fistulae after treatment of atrial fibrillation by catheter ablation. A total of 553 729 catheter ablation procedures (radiofrequency: 62.9%, cryoballoon: 36.2%, other modalities: 0.9%) were performed, at 214 centres in 35 countries. In 78 centres 138 patients [0.025%, radiofrequency: 0.038%, cryoballoon: 0.0015% (P < 0.0001)] were diagnosed with an oesophageal fistula. Peri-procedural data were available for 118 patients (85.5%). Following catheter ablation, the median time to symptoms and the median time to diagnosis were 18 (7.75, 25; range: 0–60) days and 21 (15, 29.5; range: 2–63) days, respectively. The median time from symptom onset to oesophageal fistula diagnosis was 3 (1, 9; range: 0–42) days. The most common initial symptom was fever (59.3%). The diagnosis was established by chest computed tomography in 80.2% of patients. Oesophageal surgery was performed in 47.4% and direct endoscopic treatment in 19.8% and conservative treatment in 32.8% of patients. The overall mortality was 65.8%. Mortality following surgical (51.9%) or endoscopic treatment (56.5%) was significantly lower as compared to conservative management (89.5%) [odds ratio 7.463 (2.414, 23.072) P < 0.001]. Conclusion Oesophageal fistula after catheter ablation of atrial fibrillation is rare and occurs mostly with the use of radiofrequency energy rather than cryoenergy. Mortality without surgical or endoscopic intervention is exceedingly high. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
39. Aortoesophageal fistula involving the central aortic arch salvaged with emergent percutaneous TEVAR, great vessel coverage and in vivo graft fenestration
- Author
-
Lee, Shimwoo, Division of Vascular and Interventional Radiology, Department of Radiology, Srinivasa, Ravi N, Rigberg, David A, Yanagawa, Jane, Benharash, Peyman, Moriarty, John M, Division of Vascular Surgery, Department of Surgery, and Division of Thoracic Surgery, Department of Surgery
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Cardiovascular ,Adult ,Aorta ,Thoracic ,Aortic Diseases ,Blood Vessel Prosthesis Implantation ,Endovascular Procedures ,Esophageal Fistula ,Female ,Gastrointestinal Hemorrhage ,Humans ,Stents ,Treatment Outcome ,Vascular Fistula ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
Immediate intervention is needed for aortoesophageal fistulas (AEF), a rare but highly lethal cause of massive gastrointestinal hemorrhage. Emergent thoracic endovascular aortic repair (TEVAR) is considered first-line treatment for massive bleeding from AEFs. We describe an unusual and challenging case of TEVAR coverage of an AEF involving the central aortic arch immediately followed by in vivo endograft fenestration to regain arch vessel perfusion. In vivo fenestration, currently a procedure for emergency or investigational purposes only, was shown to be life saving in our case. The main complications associated with the procedure included stroke and infection, requiring esophagectomy and cervical diversion as well as ongoing antibiotic treatment.
- Published
- 2021
40. Closure of esophageal-pleural fistula using a cardiac occluder in a patient with systemic scleroderma.
- Author
-
Kiosov, Oleksandr, Tkachov, Vladyslav, and Gulevskyi, Sergii
- Subjects
- *
ESOPHAGEAL fistula , *SURGERY , *SYSTEMIC scleroderma , *ATRIAL septal defects , *LITERATURE reviews - Abstract
This article, published in Clinical Endoscopy, discusses the closure of an esophageal-pleural fistula using a cardiac occluder in a patient with systemic scleroderma. The patient had previously undergone a thoracotomy and diverticulectomy for a midesophageal diverticulum, but a fistula formed postoperatively. Various methods were attempted to close the fistula, including stents, glue, and surgical sponges, but were unsuccessful. Ultimately, a cardiac occluder was used to successfully close the fistula, and the patient experienced no recurrence three months later. The article suggests that non-standard approaches, such as using a cardiac occluder, may be effective in treating fistulas in patients with systemic scleroderma. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
41. Mediastinal lymph node tuberculosis complicated with esophageal fistula: A case report.
- Author
-
Zemin, He, Keting, Liu, and Wei, Qiang
- Published
- 2024
- Full Text
- View/download PDF
42. Successful management of a child with bronchoesophageal fistula associated with other anomalies.
- Author
-
Raghunath, B, Angadi, Kavya, Gurudutt, A, Srinivas, Nidhi, Manjunath, L, and Madhu, S
- Subjects
- *
X-rays , *ESOPHAGEAL fistula , *CHEST X rays , *BRONCHIAL fistula , *TREATMENT effectiveness , *ABDOMINAL surgery , *COMPUTED tomography , *CHILDREN - Abstract
Bronchoesophageal fistulas (BEFs) are rare malformations characterized by abnormal communication between the bronchus and the esophagus. Herein, we report a successful management of a child with BEF discovered as an intraoperative surprise and associated with the short gut, annular pancreas, and disorder of intestinal fixation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. Boerhaave syndrome complicated by subsequent esophageal stenosis and esophageal fistula.
- Author
-
Kwiatkowska, Natalia Maria, Kaminska, Alicja, Sielewicz, Magdalena, Kasprzyk, Mariusz, and Piwkowski, Cezary
- Subjects
- *
ESOPHAGEAL fistula , *ESOPHAGEAL stenosis , *ESOPHAGEAL perforation , *SYNDROMES , *SUBCUTANEOUS emphysema , *PNEUMOMEDIASTINUM - Abstract
This article discusses a case of Boerhaave syndrome, a rare condition characterized by a spontaneous rupture of the esophagus. The syndrome is typically caused by forceful vomiting and has a high mortality rate. Early detection is crucial for reducing the mortality rate, but the diagnosis is often complicated by other differential diagnoses. Treatment involves surgical intervention and broad-spectrum antibiotics. The article also describes the specific case of a 32-year-old male with Boerhaave syndrome who developed subsequent esophageal stenosis and an esophageal fistula. The patient underwent various procedures and therapies to manage these complications. The article emphasizes the importance of early diagnosis and treatment in reducing mortality and highlights the challenges in diagnosing and managing Boerhaave syndrome. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
44. Aberrant right subclavian artery complicated by acquired hemophilia A and a subclavian artery–esophageal fistula after traumatic injury.
- Author
-
Hirayu, Nobuhisa, Fukuda, Masafumi, Nabeta, Masakazu, and Takasu, Osamu
- Subjects
- *
HEMOPHILIA complications , *SUBCLAVIAN artery , *ESOPHAGEAL fistula , *TRAFFIC accidents , *RIGHT heart ventricle , *THERAPEUTIC embolization , *HOSPITAL care , *RARE diseases ,SUBCLAVIAN artery surgery - Abstract
An aberrant right subclavian artery (ARSA) is a rare developmental anomaly wherein the right subclavian artery arises from the descending aorta as a fourth branch of the aortic arch. We present the case of ARSA in an 81-year-old woman who was injured in a motorcycle accident. The patient had a history of asymptomatic cerebral infarction, type 2 diabetes mellitus, and rheumatoid arthritis. She was diagnosed with spleen and liver injury, left renal injury, along with fractures in the rib, pelvic, vertebrae, and right tibia. On the 3rd hospitalization day, activated partial thromboplastin time (APTT) prolongation was observed, followed by sudden massive hematemesis and shock on the 39th day. We indicate sudden hematemesis and ARSA bleeding as the cause. We performed compression with a Sengstaken–Blakemore tube and coil embolization for hemostasis. Our findings show that the bleeding was mainly caused by nasogastric tube compression, prolonged APTT, and acquired hemophilia A. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Neurodevelopmental outcomes in individuals with VACTERL association. A population-based cohort study.
- Author
-
Kassa, Ann-Marie and Lilja, Helene Engstrand
- Subjects
- *
ESOPHAGEAL fistula , *ATTENTION-deficit hyperactivity disorder , *PROPORTIONAL hazards models , *AUTISM spectrum disorders ,ESOPHAGEAL atresia - Abstract
Background: Studies on neurodevelopmental outcomes in individuals with congenital anomalies who undergo neonatal surgery are scarce and have reported contradictory findings based on small study groups. The congenital condition VACTERL association includes at least three malformations: vertebral anomalies, anorectal malformations, cardiac defects, tracheoesophageal fistula with or without esophageal atresia, renal anomalies and limb deformities. Most of these patients undergo surgery during their first days of life. Neurodevelopmental disorders include a broad group of disabilities involving some form of disruption to brain development. Attention deficit hyperactivity disorder (ADHD), autism spectrum disorders (ASD) and intellectual disability (ID) are diagnoses included in this group. The aim of the study was to investigate the risk of ADHD, ASD and ID in a cohort of individuals with VACTERL association. Method: Data was obtained from four Swedish national health registers and analyzed using the Cox proportional hazards model. Patients born 1973–2018 in Sweden with the diagnosis of VACTERL association were included in the study. For each case five healthy controls matched for sex, gestational age at birth, birth year and birth county were obtained. Results: The study included 136 individuals with VACTERL association and 680 controls. Individuals with VACTERL had significantly higher risk of ADHD, ASD and ID than the controls; 2.25 (95% CI, 1.03–4.91), 5.15 (95% CI, 1.93–13.72) and 8.13 (95% CI, 2.66–24.87) times respectively. Conclusions: A higher risk of ADHD, ASD and ID was found among individuals with VACTERL association compared to controls. These results are of importance to caregivers and to professionals participating in follow ups of these patients in providing early diagnosis and support, aiming to optimize the quality of life of these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Atrio-Esophageal Fistula Following Left Atrial Ablation for the Treatment of Atrial Fibrillation: A Report of 2 Cases.
- Author
-
Grinberg, Reudor, Ilgiyaev, Eduard, Rapoport, Avigal, Hochman, Yuval, Miltau, Danny, Golman, Nina, and Hai, Yaron
- Subjects
- *
ATRIAL fibrillation , *ATRIAL flutter , *LEFT heart atrium , *LOSS of consciousness , *FISTULA , *STROKE - Abstract
Objective: Rare disease Background: Atrial fibrillation is a common arrhythmia worldwide. The number of patients undergoing ablation as treatment is increasing, as is the incidence of complications from ablation. One such complication is atrio-esophageal fistula, which is rare but life threatening. We discuss 2 cases of patients that presented with a fistula several weeks following atrial fibrillation ablation. Case Reports: A 67-year-old man and 64-year-old woman both had cardiovascular morbidity and chronic kidney disease, diabetes, and other chronic illnesses. Both patients presented approximately 6 weeks after radiofrequency atrial fibrillation ablation and were admitted with varying symptoms, including fever and neurological deficits mimicking a cerebrovascular accident or massive bleeding. Both patients deteriorated very rapidly in the department, especially after certain interventions, such as endoscopy, and exhibited deteriorating neurological signs, including loss of consciousness and basic brain stem reflexes, and head computed tomography (CT) showed widespread infarcts and hemorrhages. Owing to their history, a chest CT was performed at the same time, revealing an atrio-esophageal fistula, which was determined to be the cause of their illness and led to their eventual deaths. Conclusions: A rare complication of atrial fibrillation ablation procedure is atrio-esophageal fistula, which if left untreated, is almost uniformly fatal, and even survivors are usually left with significant sequelae. It is important to recognize the rapid deterioration and possible signs and symptoms, such as gastrointestinal bleeding, fever, or even neurological abnormalities, and make the connection to the ablation procedure in terms of timeline for rapid diagnosis and prompt treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Diagnosing and treating esophageal obstruction in camels (Camelus dromedarius).
- Author
-
Sadan, Madeh, El-Khodery, Sabry, Almatroodi, Saleh, Alsobayil, Fahd, and El-Shafaey, El-Sayed
- Subjects
- *
CAMELS , *ASPARTATE aminotransferase , *ESOPHAGEAL fistula , *CREATINE kinase , *BLOOD urea nitrogen , *ALANINE aminotransferase , *GAMMA-glutamyltransferase - Abstract
Background and Aim: Esophageal obstruction is a common occurrence and a serious condition in camels. This study aimed to assess the effects of mineral deficiency on esophageal obstruction rates in dromedary camels and describe their clinical presentation and treatment outcomes. Materials and Methods: Twenty-eight camels were allocated to two groups. Group 1 (control) was composed of 10 sound camels. Group 2 included 18 camels with esophageal obstruction which were based on clinical and imaging evaluations. Hematobiochemical examinations in control and affected camels were compared and statistically analyzed. Results: In camels with esophageal obstruction when compared with controls, hematological analyses showed significant increases (p < 0.05) in neutrophils, lymphocytes, and monocytes, along with significantly decreased total white blood counts. Aspartate transaminase, alanine transaminase, alkaline phosphatase, creatine phosphokinase, glucose, albumin, creatinine, and blood urea nitrogen concentrations were significantly higher in affected camels when compared with controls. Furthermore, gamma-glutamyl transferase, globulin, sodium, chloride, cobalt, iron, manganese, and selenium concentrations were significantly reduced. Affected camels were treated by stomach tube or surgery and were completely recovered, except for one camel with an esophageal fistula. Conclusion: A lack of trace elements could have a significant role in esophageal obstruction in dromedaries. Clinical, ultrasonographic, and hematobiochemical evaluations are useful for the accurate diagnosis, prognosis, and treatment of esophageal obstruction in camels. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. The Use of Esophageal Stents in the Management of Postoperative Fistulas—Current Status, Clinical Outcomes and Perspectives—Review.
- Author
-
Rosianu, Cristian Gelu, Hoara, Petre, Achim, Florin, Birla, Rodica, Bolocan, Alexandra, Mohssen, Ahmed, Copca, Narcis, and Constantinoiu, Silviu
- Subjects
- *
ESOPHAGEAL fistula , *POSTOPERATIVE care , *TREATMENT effectiveness , *FISTULA , *SURGICAL stents , *SURGICAL complications , *DEEP brain stimulation - Abstract
Esophageal fistula remains one of the main postoperative complications, with the treatment often requiring the use of stents. This article reviews the updates on the use of endoscopic stents for the treatment of postoperative esophageal leakage in terms of indications, types of stents used, efficiency, specific complications and perspectives. Materials and Methods: We searched the PubMed and MEDLINE databases for the keywords postoperative esophageal anastomotic leak and postoperative esophageal anastomotic leak stent, and retrieved relevant papers published until December 2022. Results: The endoscopic discovery of the fistula is usually followed by the insertion of a fully covered esophageal stent. It has an efficiency of more than 60% in closing the fistula, and the failure is related to the delayed application of the method, a situation more suitable for endo vac therapy. The most common complication is migration, but life-threatening complications have also been described. The combination of the advantages of endoscopic stents and vacuum therapy is probably found in the emerging VACstent procedure. Conclusions: Although the competing approaches give promising results, this method has a well-defined place in the treatment of esophageal fistulas, and it is probably necessary to refine the indications for each individual procedure. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy
- Author
-
Yan-Jie Shi, Chang Liu, Yi-Yuan Wei, Xiao-Ting Li, Lin Shen, Zhi-Hao Lu, and Ying-Shi Sun
- Subjects
Esophageal squamous cell cancer ,X-ray computed tomography ,Esophageal fistula ,Risk factor ,Chemoradiotherapy ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Esophageal fistula is one of the most serious complications of chemotherapy or chemoradiotherapy (CRT) for advanced esophageal cancer. This study aimed to evaluate the performance of quantitative computed tomography (CT) analysis and to establish a practical imaging model for predicting esophageal fistula in esophageal cancer patients treated with chemotherapy or chemoradiotherapy. Methods This study retrospectively enrolled 204 esophageal cancer patients (54 patients with fistula, 150 patients without fistula) and all patients were allocated to the primary and validation cohorts according to the time of inclusion in a 1:1 ratio. Ulcer depth, tumor thickness and length, and minimum and maximum enhanced CT values of esophageal cancer were measured in pretreatment CT imaging. Logistic regression analysis was used to evaluate the associations of CT quantitative measurements with esophageal fistula. Receiver operating characteristic curve (ROC) analysis was also used. Results Logistic regression analysis showed that independent predictors of esophageal fistula included tumor thickness [odds ratio (OR) = 1.167; p = 0.037], the ratio of ulcer depth to adjacent tumor thickness (OR = 164.947; p
- Published
- 2022
- Full Text
- View/download PDF
50. Aberrant right subclavian artery complicated by acquired hemophilia A and a subclavian artery–esophageal fistula after traumatic injury
- Author
-
Nobuhisa Hirayu, Masafumi Fukuda, Masakazu Nabeta, and Osamu Takasu
- Subjects
aberrant right subclavian artery ,acquired hemophilia a ,complication ,esophageal fistula ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
An aberrant right subclavian artery (ARSA) is a rare developmental anomaly wherein the right subclavian artery arises from the descending aorta as a fourth branch of the aortic arch. We present the case of ARSA in an 81-year-old woman who was injured in a motorcycle accident. The patient had a history of asymptomatic cerebral infarction, type 2 diabetes mellitus, and rheumatoid arthritis. She was diagnosed with spleen and liver injury, left renal injury, along with fractures in the rib, pelvic, vertebrae, and right tibia. On the 3rd hospitalization day, activated partial thromboplastin time (APTT) prolongation was observed, followed by sudden massive hematemesis and shock on the 39th day. We indicate sudden hematemesis and ARSA bleeding as the cause. We performed compression with a Sengstaken–Blakemore tube and coil embolization for hemostasis. Our findings show that the bleeding was mainly caused by nasogastric tube compression, prolonged APTT, and acquired hemophilia A.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.